Suppr超能文献

皮质醇受体抵抗:其临床表现及治疗反应的变异性

Cortisol receptor resistance: the variability of its clinical presentation and response to treatment.

作者信息

Lamberts S W, Koper J W, Biemond P, den Holder F H, de Jong F H

机构信息

Department of Medicine, Erasmus University, Rotterdam, The Netherlands.

出版信息

J Clin Endocrinol Metab. 1992 Feb;74(2):313-21. doi: 10.1210/jcem.74.2.1309833.

Abstract

Primary (partial) cortisol receptor resistance was previously reported in a total of 7 patients and 14 asymptomatic family members. Its occurrence is considered to be extremely rare. In the present study we report on 6 patients (2 males and 4 females) with the syndrome. The first male patient presented with mild hypertension. Hydrochlorothiazide therapy resulted in life-threatening hypokalemia. The second male patient had slight hypertension without hypokalemia. All four female patients presented between the age of 20-30 yr with acne, hirsutism, and irregular menstruations. Low dose dexamethasone therapy (1-1.5 mg/day) was of clinical benefit in these patients. All patients showed insufficient suppression of serum cortisol concentrations in the overnight 1-mg dexamethasone test. The diurnal rhythm of ACTH and cortisol was intact, albeit at an elevated level. There was a normal increase in ACTH, cortisol, and GH (except in one obese patient) in response to insulin-induced hypoglycemia, while cortisol production was elevated in three patients. Circulating adrenal androgen levels were increased in all patients. Glucocorticoid receptors were investigated in a whole cell dexamethasone binding assay in mononuclear leukocytes. In the first male patient, the number of receptors was very low, while the affinity was lower than that in controls. A lowered affinity to dexamethasone was found in one female patient, while a lowered number of receptors was found in three patients. In the second male patient, no abnormalities were found. As a bioassay for glucocorticoid action we also measured dexamethasone suppressibility of mitogen-stimulated incorporation of [3H]thymidine in mononuclear leukocytes. In the male patient with normal receptor status, dexamethasone suppressibility of [3H]thymidine incorporation was significantly lower than that in healthy controls with respect to both maximal suppression and IC50. Partial cortisol receptor resistance might be less rare than previously thought. In the six patients presented, at least three different forms can be recognized. Therapy with dexamethasone was successful in female patients with acne and hirsutism, as the secondary increase in the production of adrenal androgens was effectively controlled.

摘要

先前总共报道了7例原发性(部分性)皮质醇受体抵抗患者以及14名无症状家庭成员。其发生率被认为极其罕见。在本研究中,我们报告了6例患有该综合征的患者(2名男性和4名女性)。第一名男性患者表现为轻度高血压。氢氯噻嗪治疗导致危及生命的低钾血症。第二名男性患者有轻度高血压但无低钾血症。所有四名女性患者年龄在20至30岁之间,出现痤疮、多毛症和月经不规律。低剂量地塞米松治疗(1 - 1.5毫克/天)对这些患者有临床益处。所有患者在夜间1毫克地塞米松试验中血清皮质醇浓度抑制不足。促肾上腺皮质激素(ACTH)和皮质醇的昼夜节律完好,尽管处于升高水平。在胰岛素诱导的低血糖反应中,ACTH、皮质醇和生长激素(GH)(一名肥胖患者除外)有正常升高,而三名患者的皮质醇分泌升高。所有患者循环肾上腺雄激素水平升高。在单核白细胞的全细胞地塞米松结合试验中研究了糖皮质激素受体。在第一名男性患者中,受体数量非常低,而亲和力低于对照组。在一名女性患者中发现对地塞米松的亲和力降低,而在三名患者中发现受体数量减少。在第二名男性患者中未发现异常。作为糖皮质激素作用的生物测定,我们还测量了地塞米松对单核白细胞中丝裂原刺激的[3H]胸腺嘧啶掺入的抑制能力。在受体状态正常的男性患者中,[3H]胸腺嘧啶掺入的地塞米松抑制能力在最大抑制和半数抑制浓度(IC50)方面均显著低于健康对照组。部分性皮质醇受体抵抗可能比先前认为的更为常见。在所呈现的6例患者中,至少可识别出三种不同形式。地塞米松治疗对患有痤疮和多毛症的女性患者成功,因为肾上腺雄激素分泌的继发性增加得到有效控制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验